Evidence map›Paper›PMID 26972035›Full record

ReviewSleep medicine clinics2016

Sleep Duration and Cardiovascular Disease Risk: Epidemiologic and Experimental Evidence.

Naima Covassin, Prachi Singh

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Sleep medicine clinics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Sleep status among adults.Sleep & breathing = Schlaf & Atmung · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Naima CovassinDivision of Cardiovascular Diseases, Mayo Clinic, 200 First Street, Rochester, MN 55905, USA. Electronic address: covassin.naima@mayo.edu.
Prachi SinghDivision of Cardiovascular Diseases, Mayo Clinic, 200 First Street, Rochester, MN 55905, USA.

Funding

Sleep Restriction and Augmented Vascular Risk in PrehypertensionR01HL114676 · NHLBI · MAYO CLINIC ROCHESTER · PI SOMERS, VIREND K · 2012 to 2016
$2.4M
American Heart Association-American Stroke Association 11SDG7260046NHLBI NIH HHS R01 HL114676
6 · The paper itself

Abstract

Inadequate sleep is increasingly pervasive, and the impact on health remains to be fully understood. The cardiovascular consequences alone appear to be substantial. This review summarizes epidemiologic evidence regarding the association between extremes of sleep duration and the prevalence and incidence of cardiovascular diseases. The adverse effects of experimental sleep loss on physiological functions are discussed, along with cardiovascular risk factors that may underlie the association with increased morbidity and mortality. Current data support the concept that inadequate sleep duration confers heightened cardiovascular risk. Thus implementation of preventative strategies may reduce the potential disease burden associated with this high-risk behavior.

Indexed as

Cardiovascular DiseasesHumansSleepCardiovascular diseaseCoronary heart diseaseHypertensionSleep deprivationSleep durationStroke

Identifiers

PMID26972035
PMCPMC4791534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.